KMT2A is of particular interest since it was found in the early 1990s to be part of recurrent fusion oncogenes that occur in acute myeloid‐ and lymphoid leukemia (AML/ALL).4, 5, 6, 7. The gene discussed is KMT2A; the disease is acute lymphoblastic leukemia.